Popular on TelAve
- Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
- Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
- SPOZZ, the Community-Owned Direct-to-Fan Music Ecosystem, adds "BEATS" — a Creator-to-Creator Marketplace
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- Los Angeles Community Recovery Investment Fund Launches Innovative Platform
- AdvisorVault Releases New Explainer Video on their 17a-4 Managed 365 Service
- Jaipur's Savista Retreat announces $299 all-inclusive nightly rate for two for the 2026 season, including meals and city-center transfers
- Phinge Effect: How Billions in VC Funding Could Shift From Current Tech, AI & App-Store Developers to Fund Third-Party Platform Developers on Netverse
- Applications Now Open for Raymond James Gasparilla Festival of the Arts Emerging Artists Program
- DGiTK – Digital Technologies, LLC Announces Groundbreaking Partnership with Hyperscale Compute Partner to Revolutionize Data Sovereignty in the U.S
Similar on TelAve
- Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
- Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
- Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
- PatientNow Acquires Recura, the AI Growth Engine Powering Practice Growth
- Genuine Smiles Unveils New User-Friendly Website
- The Citizens Commission on Human Rights of Florida Celebrates Volunteers and Community Partners at the 9th Annual Humanitarian Awards Banquet
- Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching?
- Launch of Professional Private Autopsy Services to Support Families, Professionals, and Researchers
- TRUE Palliative Care Launches as California Strengthens Commitment to Compassionate Care Under SB 403
Phinge Seeks to Facilitate Breakthroughs in Cancer Research with Upcoming Netverse Hardware-Verified, App-less Technologies, Platform & Verified AI
TelAve News/10879625
INCLINE VILLAGE, Nev. - TelAve -- Following its recent announcement detailing its upcoming Netverse® platform's potential capabilities for securing clinical trials, Phinge® is highlighting how the same patented, hardware-verified technology can revolutionize research for cancer and other diseases.
By eliminating vulnerable apps and centralizing verification at the device level, Netverse will enable secure, decentralized, and patient-centric studies for treating diseases like cancer. This advancement could address critical challenges in oncology and other research, from data integrity to patient recruitment, ultimately accelerating the development of life-saving therapies.
Netverse's patented app-less technology and hardware-verified identity could offer a new paradigm for research into cancer and other diseases. The decentralized, zero-trust framework will empower researchers to collect highly accurate and private data directly from participants, replacing vulnerable apps with a secure, all-in-one platform. This approach would improve data integrity, enhances patient recruitment, and accelerates the development of new cancer treatments.
Netverse: Reshaping Cancer Research with Verified Technology
Cancer research faces long-standing challenges related to data integrity, patient privacy, and participation. In a traditional research setting, data is often collected through disparate systems and apps, creating vulnerabilities to security breaches and identity fraud. Phinge's Netverse platform is being engineered to address these issues head-on, leveraging its patented hardware to provide a verified, secure, and user-centric experience. https://www.ncbi.nlm.nih.gov/books/NBK233428/
More on TelAve News
By providing an app-less, hardware-verified platform, Netverse is poised to transform research for cancer and other diseases. Phinge's Netverse platform's commitment to security, decentralization, and patient empowerment will enable more robust, inclusive, and efficient clinical trials. This move could accelerate the discovery and delivery of new treatments, ultimately improving outcomes for cancer patients worldwide.
More on TelAve News
"My mom passed away from cancer, so anything that could be done to achieve prevention or find a quicker cure is a primary focus of mine," says Robert DeMaio, Phinge Corporation's Founder and CEO.
Preview Netverse and its patented, magnetically attachable smartphones and devices by visiting Phinge's websites at
https://www.phinge.com
To get on a contact list, please fill out the online form here
https://www.phinge.com/netverseai.html
Ask Google Gemini about Netverse here
https://www.phinge.com/get-netverse.html
View Phinge's Crunchbase profile here
https://www.crunchbase.com/organization/phinge
View Phinge CEO Robert DeMaio's Crunchbase profile here
https://www.crunchbase.com/person/robert-charles-demaio
Phinge CEO Spoke at Strong AI Summit 2025
https://youtu.be/c_du6wniqLY
About Phinge Corporation
Phinge was founded and through Netverse® is being developed to disrupt today's outdated App technologies, including the App-store duopoly, by partnering with and giving its users and businesses ownership and control of their data, enhanced privacy and a better overall mobile experience including their ability to monetize it.
Phinge through its upcoming patented Netverse App-less technology platform with proprietary AI, will be a better, safer, verified and rewarding alternative platform and technology for users and third party businesses and developers to today's App stores, operating systems and ecosystems of Apple, Google and Android.
Netverse will not be an App or Super App that resides on the major technology platforms of today.
Instead, it will be a standalone, all-in-one, app-less platform, accessible only through Phinge's revolutionary, patented, Mobile Hardware which includes Magnetically Attachable/Detachable Phones, Tablets, Mobile Gaming Systems and peripherals like the stylish, wireless earbuds with interchangeable batteries and built-in sensor screens for continuous usage without recharging. Smart Watches that never need to be physically charged as they come with stylish external, interchangeable bezels with built-in rechargeable batteries and come in a variety of colors, patterns and finishes.
Netverse will be a verified, centralized-decentralized platform.
Centralized in the way it provides universal safeguards through verification of all users, businesses, organizations, entities and IP through Phinge's patented Netverse technologies and hardware.
Centralized because Phinge and Netverse will be compliant with all government regulations regarding data and privacy.
Decentralized because all third party platforms will be compliant with all government regulations regarding data and privacy as soon as they are verified and join Netverse.
Decentralized because its users, businesses, organizations and entities will have the power to live, work and thrive in a verified world.
Netverse will benefit all verified users and approved, verified third party businesses, developers and platforms on Netverse in ways not possible with today's technology including total verification of all users, businesses, organizations, platforms.
By eliminating vulnerable apps and centralizing verification at the device level, Netverse will enable secure, decentralized, and patient-centric studies for treating diseases like cancer. This advancement could address critical challenges in oncology and other research, from data integrity to patient recruitment, ultimately accelerating the development of life-saving therapies.
Netverse's patented app-less technology and hardware-verified identity could offer a new paradigm for research into cancer and other diseases. The decentralized, zero-trust framework will empower researchers to collect highly accurate and private data directly from participants, replacing vulnerable apps with a secure, all-in-one platform. This approach would improve data integrity, enhances patient recruitment, and accelerates the development of new cancer treatments.
Netverse: Reshaping Cancer Research with Verified Technology
Cancer research faces long-standing challenges related to data integrity, patient privacy, and participation. In a traditional research setting, data is often collected through disparate systems and apps, creating vulnerabilities to security breaches and identity fraud. Phinge's Netverse platform is being engineered to address these issues head-on, leveraging its patented hardware to provide a verified, secure, and user-centric experience. https://www.ncbi.nlm.nih.gov/books/NBK233428/
- Secure Remote Monitoring: The app-less architecture will allow participants to securely use Netverse-enabled hardware to provide biometric data, report symptoms, and log treatment adherence without the security risks of traditional mobile apps. This decentralized approach is particularly beneficial for cancer patients who may have limited mobility or live in remote areas, significantly increasing the diversity and scale of clinical trials.
- Enhanced Data Integrity: By verifying participants directly through their Netverse hardware, the platform will ensure that the data is authentic and comes from the intended source. This is a fundamental shift from relying on software-based identity, which is susceptible to tampering. For cancer research, this means higher confidence in reported outcomes, from quality-of-life metrics to treatment-related side effects.
- Patient-Controlled Privacy: With Netverse's decentralized, zero-trust model, each participant would retain ownership and control over their data. This model will build trust with patients, who may be hesitant to share sensitive health information. By giving them full transparency and control over who accesses their data, Netverse can increase participation and retention in critical cancer studies.
More on TelAve News
- $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST
- Wzzph Deploys 5-Million-TPS Trading Engine with Hot-Cold Wallet Architecture Serving 500,000 Active Users Across Latin America
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
- $73.6 Million Multi-Year Backlog and Florida State Term Contract Drive Momentum for AI-Cybersecurity Pioneer: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
- Year-Round Deals for Customers With Square Signs
| Feature | Traditional Research Methods | Netverse-Enabled Cancer Research |
| Identity Verification | Relies on software-based authentication and manual identity checks, creating vulnerabilities to fraud. | Will use patented hardware to verify the user's identity, ensuring data authenticity and preventing identity fraud. |
| Data Collection | Dependent on multiple apps, websites, and in-person visits, leading to fragmented data, security risks, and data entry errors. | Will use a single, app-less platform on Netverse hardware, providing a seamless, secure, and integrated data stream. |
| Security Model | Centralized, offering a single point of failure and vulnerability to large-scale data breaches. | Decentralized with a zero-trust framework, assuming a breach and verifying every request to protect patient data. |
| Patient Privacy | Patients may have limited control over who accesses their sensitive health information. | Patient is the sole custodian of their data, with end-to-end encryption and full control over access permissions. |
| Patient Recruitment & Retention | In-person visit requirements can create barriers for patients, especially those in vulnerable health states or remote areas, potentially limiting study diversity. | Enables remote, decentralized trials, reducing the burden on patients and allowing for broader, more inclusive participant pools. |
By providing an app-less, hardware-verified platform, Netverse is poised to transform research for cancer and other diseases. Phinge's Netverse platform's commitment to security, decentralization, and patient empowerment will enable more robust, inclusive, and efficient clinical trials. This move could accelerate the discovery and delivery of new treatments, ultimately improving outcomes for cancer patients worldwide.
More on TelAve News
- SecurePII Raises US$3.5M (A$5M) to Unlock AI and Compliance for Voice Data and Expands Global Presence
- Peter Coe Verbica Stands with Rural Families and Horse Owners: "Keep Horses Classified as Livestock"
- The Mobile-First Company Raises $12M to Build Simple, Powerful Software for Small Teams
- Lick Pineapple Flavored Massage Oil Outperforming and Enticing
- Cerberus ODC in Collaboration with NVIDIA Launches All-American AI-RAN Stack, Enabling AI-Native 5G Today and Accelerating the Path to 6G
"My mom passed away from cancer, so anything that could be done to achieve prevention or find a quicker cure is a primary focus of mine," says Robert DeMaio, Phinge Corporation's Founder and CEO.
Preview Netverse and its patented, magnetically attachable smartphones and devices by visiting Phinge's websites at
https://www.phinge.com
To get on a contact list, please fill out the online form here
https://www.phinge.com/netverseai.html
Ask Google Gemini about Netverse here
https://www.phinge.com/get-netverse.html
View Phinge's Crunchbase profile here
https://www.crunchbase.com/organization/phinge
View Phinge CEO Robert DeMaio's Crunchbase profile here
https://www.crunchbase.com/person/robert-charles-demaio
Phinge CEO Spoke at Strong AI Summit 2025
https://youtu.be/c_du6wniqLY
About Phinge Corporation
Phinge was founded and through Netverse® is being developed to disrupt today's outdated App technologies, including the App-store duopoly, by partnering with and giving its users and businesses ownership and control of their data, enhanced privacy and a better overall mobile experience including their ability to monetize it.
Phinge through its upcoming patented Netverse App-less technology platform with proprietary AI, will be a better, safer, verified and rewarding alternative platform and technology for users and third party businesses and developers to today's App stores, operating systems and ecosystems of Apple, Google and Android.
Netverse will not be an App or Super App that resides on the major technology platforms of today.
Instead, it will be a standalone, all-in-one, app-less platform, accessible only through Phinge's revolutionary, patented, Mobile Hardware which includes Magnetically Attachable/Detachable Phones, Tablets, Mobile Gaming Systems and peripherals like the stylish, wireless earbuds with interchangeable batteries and built-in sensor screens for continuous usage without recharging. Smart Watches that never need to be physically charged as they come with stylish external, interchangeable bezels with built-in rechargeable batteries and come in a variety of colors, patterns and finishes.
Netverse will be a verified, centralized-decentralized platform.
Centralized in the way it provides universal safeguards through verification of all users, businesses, organizations, entities and IP through Phinge's patented Netverse technologies and hardware.
Centralized because Phinge and Netverse will be compliant with all government regulations regarding data and privacy.
Decentralized because all third party platforms will be compliant with all government regulations regarding data and privacy as soon as they are verified and join Netverse.
Decentralized because its users, businesses, organizations and entities will have the power to live, work and thrive in a verified world.
Netverse will benefit all verified users and approved, verified third party businesses, developers and platforms on Netverse in ways not possible with today's technology including total verification of all users, businesses, organizations, platforms.
Source: Phinge Corporation
0 Comments
Latest on TelAve News
- Boston Industrial Solutions Unveils New and Improved Natron® UV Screen Printing Ink
- Genuine Smiles Unveils New User-Friendly Website
- Nusign Global Launch Event Concludes Successfully, Embarking on a New International Chapter
- Lift Solutions Holdings Announces Exclusive Distributorship for Advanced Camera and Sensor Products from Automate Matrix
- Political Division and Safety Concerns Drive Record Number of Americans to Seek "Golden Visas," La Vida Survey Finds
- The Citizens Commission on Human Rights of Florida Celebrates Volunteers and Community Partners at the 9th Annual Humanitarian Awards Banquet
- J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation
- Words of Veterans & Veterans Growing America Collaboration
- Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching?
- Engaged at Any Age: 73-Year-Old Client Finds True Love Through Elite Asian Matchmaker
- Launch of Professional Private Autopsy Services to Support Families, Professionals, and Researchers
- He Started a New Career at 77; Maybe Not His Last
- "The Art of Philanthropy" — A Year-Long Campaign Supporting the USO and Military Veterans
- TRUE Palliative Care Launches as California Strengthens Commitment to Compassionate Care Under SB 403
- Cell Tower AI Launches AI Platform Powered by ChatGPT to Disrupt the Cell Tower Industry
- Mysterious Interstellar Object 3I/ATLAS Appears to Pause Near Mars, Exhibiting Periodic Light Pulses
- $73.6 Million in Order Backlog Poised for Explosive Growth in 2026; Streamlined Share Structure: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
- Osric Langevin Unveils "Quantitative Trend" Framework for Multi-Asset Analysis in Q4 2025
- Experience Days Named Among the UK's Top Christmas Gifts
- New Free Educational Bingo Cards Make Learning English Fun for First Graders
